Envarsus XL Immunosuppression Following Liver Transplantation

NCT03828058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Recipients of Liver Transplant

Interventions

DRUG: Envarsus XR
DRUG: Prograf

Sponsor

Methodist Healthcare